Related Experiment Video
Updated: Mar 31, 2026

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
Published on: December 3, 2019
Readmissions in HIV-Infected Inpatients: A Large Cohort Analysis
Daniel J Feller1, Matthew J Akiyama, Peter Gordon
1*New York State Department of Health (NYSDOH) AIDS Institute, New York, NY; †Division of Infectious Diseases, New York University Department of Medicine, New York, NY; and ‡Division of Infectious Diseases and New York Presbyterian Hospital, Columbia University Department of Medicine, New York, NY.
Objective:
Hospital readmissions impose considerable physical and psychological hardships on patients and represent a high, but possibly preventable, cost for insurers and hospitals alike. The objective of this study was to identify patient characteristics associated with 30-day readmission among persons living with HIV/AIDS (PLWH) using a statewide administrative database and to characterize the movement of patients between facilities.
Design:
Retrospective cohort analysis of HIV-infected individuals in New York State using a comprehensive, all-payer database.
Setting:
All hospitals in New York State.
Participants:
HIV-infected adults admitted to a medical service in 2012. PLWH identified using International Classification of Disease (ICD)-9 diagnosis codes 042 and V08.
Results:
Of 23,544 index hospitalizations, 21.8% (5121) resulted in readmission. Multivariable predictors of readmission included insurance status, housing instability, psychoses, multiple comorbid chronic conditions, substance use, and past inpatient and emergency department visits. Over 30% of readmissions occurred at a different facility than that of the initial hospitalization.
Conclusion:
A number of patient characteristics were independently associated with hospital readmission within 30 days. Behavioral health disorders and comorbid conditions may be the strongest predictors of readmission in PLWH. Readmissions, especially those in urban areas, often result in fragmented care which may compromise the quality of care and result in harmful discontinuity of medical treatment.
More Related Videos
07:10Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
Published on: January 7, 2019
13:58Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
Published on: September 26, 2011